Home › NDC Lookup › Ingredients › Loratadine › 80070-0110-60
Alavert Allergy LORATADINE 10 mg Tablet, Orally Disintegrating — NDC 80070-0110-60 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Alavert Allergy LORATADINE 10 mg Tablet, Orally Disintegrating — NDC 80070-110-60 (Billing 80070-0110-60)

by Foundation Consumer Brands · 60 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

This is a package of Alavert Allergy LORATADINE 10 mg Tablet, Orally Disintegrating from Foundation Consumer Brands, marketed since Apr 2021 and currently FDA-listed.

NDC 80070-0110-60
🏷️ FDA NDC (as labeled) 80070-110-60 billing pads the product segment with a zero
This package
Contains1 tablet, orally disintegrating in 1 blister pack Pack sizes2 compare ↓
Product page 80070-0110-18 Also comes in: 1 tablet 80070-110-18
OTC Brand On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 80070-110-60
Product NDC 80070-110
11-digit billing NDC 80070011060
RxCUI 311373, 351855
UNII 7AJO3BO7QN
Application # NDA021375
SPL Set ID f741d1cf-0ecb-4405-8596-07af394537db
DEA schedule Non-controlled
Marketing category NDA
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-04-02
Marketing end 2026-10-31
Route ORAL
Dosage form TABLET, ORALLY DISINTEGRATING
Substance LORATADINE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 41550030007220
Quick answers
  • GPI-14 (Medi-Span): 41550030007220
  • RxCUI (RxNorm): 311373
Why two NDCs? The FDA registers this code as 80070-110-60 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 80070-0110-60. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antihistamines for systemic use class.

Drug family (ATC) Other antihistamines for systemic use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📗 Our plain-language guide HelloPharmacist
  • It temporarily relieves symptoms of hay fever and other upper respiratory allergies. That means runny nose, sneezing, itchy, watery eyes, and an itchy nose or throat.
  • It is taken by mouth, generally once a day. Follow the directions on your specific product. Chewable tablets should be chewed or crushed completely, and liquids should be measured...
  • No. Do not take more than directed. Taking more than directed may cause drowsiness. If you think you took too much, get medical help or call Poison Control right away.
  • Can I take extra if my allergies are bad?
📖 Read our full Loratadine guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 1 tablet
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
80070-0110-18 80070-110-18 Main listing 18 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 2021-04-02 — Active
80070-0110-60 You're viewing this 60 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK 2021-04-02 — Active

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 60 blister pack in 1 carton / 1 tablet, orally disintegrating in 1 blister pack.
What NDC number is used to bill for this package of Alavert Allergy LORATADINE 10 mg Tablet, Orally Disintegrating?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Loratadine ODT 10 mg 00536-1367-07 Rugby 10 tablets $0.527 — Availability likely —
Loratadine ODT 10 mg 46122-0539-52 Amerisource 10 tablets $0.527 — Availability likely —
Loratadine 10 mg 72888-0029-09 Advagen 10 tablets $0.527 — Availability likely —
good sense allergy relief 10 mg 00113-1191-65 L. 1 tablet — — FDA listed —
good sense allergy relief 10 mg 00113-9755-65 L. 1 tablet — — FDA listed —
Childrens Loratadine Odt 10 mg 00363-4020-84 WALGREEN 10 tablets — — FDA listed —
Loratadine ODT 10 mg 00363-9937-84 WALGREEN 10 tablets — — FDA listed —
Claritin Reditabs 10 mg 11523-4329-01 Bayer 10 tablets — — FDA listed —
Claritin Reditabs 10 mg 11523-7157-02 Bayer 10 tablets — — FDA listed —
loratadine 10 mg 11822-0558-00 Rite 1 tablet — — FDA listed —
loratadine 10 mg 11822-0919-00 Rite 1 tablet — — Discontinued —
Loratadine ODT 10 mg 21130-0221-84 Better 10 tablets — — FDA listed —
signature care allergy relief 10 mg 21130-0301-65 Safeway 1 tablet — — Discontinued —
signature care allergy relief 10 mg 21130-0452-65 Safeway 1 tablet — — FDA listed —
allergy relief 10 mg 30142-0446-65 Kroger 1 tablet — — FDA listed —
Topcare Allergy Relief 10 mg 36800-0853-65 Topco 1 tablet — — FDA listed —
non drowsy allergy relief 10 mg 41250-0890-65 Meijer 1 tablet — — FDA listed —
careone allergy relief 10 mg 41520-0510-65 American 1 tablet — — FDA listed —
Loratadine 10 mg 43598-0707-30 Dr. 10 tablets — — FDA listed —
Loratadine 10 mg 43598-0758-10 Dr. 10 tablets — — FDA listed —
Loratadine ODT 10 mg 49035-0806-03 Wal-Mart 10 tablets — — FDA listed —
Loratadine 10 mg 51316-0503-01 CVS 10 tablets — — FDA listed —
Allergy Relief 10 mg 51316-0931-46 CVS 1 tablet — — FDA listed —
Allergy Relief 10 mg 51660-0527-31 Ohm 1 tablet — — FDA listed —
Loratadine ODT 10 mg 53943-0035-03 DISCOUNT 10 tablets — — FDA listed —
dg health allergy relief 10 mg 55910-0594-46 Dolgencorp, 1 tablet — — FDA listed —
dg health allergy relief 10 mg 55910-0970-46 Dolgencorp, 1 tablet — — FDA listed —
Allervarx 10 mg 57483-0950-10 Innovus 10 tablets — — FDA listed —
Loratadine ODT 10 mg 58602-0744-83 Aurohealth 10 tablets — — FDA listed —
Loratadine ODT 10 mg 58602-0821-83 Aurohealth 10 tablets — — FDA listed —
Loratadine ODT 10 mg 58602-0830-83 Aurohealth 10 tablets — — FDA listed —
Loratadine ODT 10 mg 58602-0881-15 Aurohealth 10 tablets — — FDA listed —
Loratadine 10 mg 59556-0917-01 Strides 10 tablets — — FDA listed —
Loratadine ODT 10 mg 60000-0950-83 Ahold 10 tablets — — FDA listed —
Loratadine ODT 10 mg 68016-0088-10 Chain 10 tablets — — FDA listed —
Alavert Allergy 10 mg 69536-0190-60 Foundation 1 tablet — — FDA listed —
Alavert Allergy 10 mg 69536-0195-20 Foundation 1 tablet — — FDA listed —
Loratadine ODT 10 mg 69842-0085-03 CVS 10 tablets — — FDA listed —
Basic Care Allergy Relief 10 mg 72288-0200-65 Amazon.com 1 tablet — — FDA listed —
Basic Care Allergy Relief 10 mg 72288-0451-65 Amazon.com 1 tablet — — FDA listed —
Loratadine 10 mg 72983-0501-01 Tenshi 10 tablets — — FDA listed —
Loratadine 10 mg 72983-0503-06 Tenshi 1 tablet — — FDA listed —
equate loratadine 10 mg 79903-0381-10 WALMART 1 tablet — — FDA listed —
Alavert Allergy 10 mgthis 80070-0110-60 Foundation 1 tablet — — FDA listed —
Alavert Allergy 10 mg 80070-0120-60 Foundation 1 tablet — — Discontinued —
Allergy Relief 10 mg 79481-9723-01 Meijer, 1 tablet — — FDA listed —
About this product: this is the brand-name version. FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Apr 2021
📍
2026
Currently FDA-listed
5 years listed
🔓
·
Generic versions listed
see equivalents
✅Generic appears available

FDA-approved generic versions are listed, and recent pricing/market data suggests they may be available — see Therapeutic equivalents.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

What it looks like

Color orange
ShapeRound
ImprintA;24
Size14 mm
ScoringNot scored
FlavorCitrus
One label can cover several strengths, so colors may be combined — always confirm a loose pill against the dispensed prescription label or a pharmacist.
Where does this data come from?
Physical description (imprint, shape, color, scoring, coating) from this product’s FDA Structured Product Labeling (SPL), mirrored from DailyMed / openFDA.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII XF417D3PSL
    Anhydrous citric acid is a sour, crystalline powder derived from citric acid with water removed. In medicines, it acts as a buffer to control pH, adds tartness to improve taste, and helps tablets disintegrate.
  • UNII Z0H242BBR1
    Aspartame is an artificial sweetener made from amino acids. It's added to medicines to improve taste, making bitter or unpleasant-tasting drugs easier to take.
  • UNII REK4960K2U
    Butylated hydroxyanisole is a synthetic preservative that prevents oils and fats in medicines from spoiling or becoming rancid. It keeps the medicine stable and extends its shelf life.
  • UNII 9G5L16BK6N
    A thick, sweet liquid made from corn starch. It acts as a sweetener, thickener, and binder in medicines, helping create the right texture and taste while holding ingredients together.
  • UNII 68401960MK
    Crospovidone is a synthetic polymer made from polyvinylpyrrolidone. It acts as a disintegrant, helping tablets break apart quickly in the stomach so the medicine dissolves and absorbs into the body.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII EX438O2MRT
    Ferric oxide yellow is a naturally occurring iron compound used as a colorant in medications. It gives tablets, capsules, and other forms a yellow or golden hue for identification and appearance.
  • UNII 2NX48Z0A9G
    Icodextrin is a glucose polymer derived from starch. It acts as a thickening agent and osmotic agent in medicines, helping to control texture and absorption in formulations like eye drops or injectable solutions.
  • UNII 70097M6I30
    Magnesium stearate is a salt made from magnesium and stearic acid, a fatty substance. It's used in tablets and capsules as a lubricant and glidant to help ingredients flow smoothly during manufacturing and prevent sticking.
  • UNII 7CVR7L4A2D
    A starch-derived carbohydrate produced by breaking down corn, potato, or tapioca starch. It functions as a filler and binder to give the medicine bulk and texture, and sometimes as a mild sweetener or texture enhancer in powders and tablets.
  • UNII 3OWL53L36A
    A natural sugar alcohol derived from seaweed or synthesized in the lab. It's used as a filler to add bulk, a sweetener in sugar-free formulas, and a disintegrant to help tablets break apart in the stomach.
  • UNII OP1R32D61U
    Microcrystalline cellulose is a purified form of cellulose, a natural fiber from plant sources. It acts as a binder and filler in tablets and capsules, helping hold ingredients together and give the medicine its shape and size.
  • UNII ETJ7Z6XBU4
    Silicon dioxide is a naturally occurring mineral used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping during manufacturing and storage.
  • UNII 8MDF5V39QO
    A white powder form of baking soda that acts as a buffer and pH regulator in medicines. It helps maintain the right acid-base balance and may aid tablet disintegration.

14 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesanhydrous citric acid, aspartame, butylated hydroxyanisole, colloidal silicon dioxide, corn syrup solids, crospovidone, dextrin, ferric oxides, magnesium stearate, maltodextrin, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerFoundation Consumer Brands
Application holderFOUNDATION CONSUMER BRANDS LLC
FDA applicationNDA021375 (NDA)
Labeler code80070
First marketedApr 2021
Product typeHuman Otc Drug
Portfolio13 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 26 words ▾

Uses temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose sneezing itchy, watery eyes itching of the nose or throat

⏱️ Dosage and Administration 48 words ▾

Directions tablet melts in mouth. Can be taken with or without water. Age Dose adults and children 6 years and over 1 tablet daily; do not use more than 1 tablet daily children under 6 ask a doctor consumers who have liver or kidney disease ask a doctor

⚠️ Warnings 109 words ▾

Warnings Do not use if you have ever had an allergic reaction to this product or any of its ingredients Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose. When using this product do not use more than directed.

Taking more than recommended may cause drowsiness. Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.

If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 18 words ▾

Other information phenylketonurics: contains phenylalanine 8.4 mg per tablet store at 20-25°C (68-77°F) keep in a dry place

🧪 Active Ingredient 8 words ▾

Active ingredient (in each tablet) Loratadine 10 mg

🧪 Inactive Ingredients 32 words ▾

Inactive ingredients anhydrous citric acid, aspartame, butylated hydroxyanisole, colloidal silicon dioxide, corn syrup solids, crospovidone, dextrin, ferric oxides, magnesium stearate, maltodextrin, mannitol, microcrystalline cellulose, modified starch, natural and artificial flavors, sodium bicarbonate

🎯 Purpose 2 words ▾

Purpose Antihistamine

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Alavert Allergy (this brand).

Top reported reactions

Fatigue3,361
Nausea2,825
Dyspnoea2,533
Headache2,511
Diarrhoea2,466
Dizziness2,184
Pain2,068

Age at onset

Neonate30
Infant16
Child333
Adolescent339
Adult5,627
Elderly3,118

Reporter sex

50,305 reports
Male · 36%
Female · 64%
Unknown · 0%

Serious outcomes

Hospitalization14,054
Death2,925
Life-threatening1,631
Disabling1,284
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 4,284 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page it is currently marketed — but Foundation Consumer Brands has reported a marketing end date of 2026-10-31, after which this package is expected to stop being marketed. The directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tablet (80070-0110-18). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Foundation Consumer Brands is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 80070-0100-12 · Foundation 80070-0120-60 · Foundation →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.